Dr Agarwal's Health Care provides a comprehensive range of eye care services, including cataract surgery, refractive surgery, and other surgeries; consultations, diagnoses, and non-surgical treatments; and sells opticals, contact lenses and accessories, and eye care-related pharmaceutical products.
The unlisted shares of Dr Agarwal's Health Care commanded a decent premium in the grey market ahead of the IPO launch.
The company's issue, analysts said, is available at a P/E ratio of 128x for FY2024 and 200x for FY2025E, indicating aggressive pricing compared to established multi-specialty hospitals in the industry."The company is concentrated only in a single specialty of the eye care market.
The story "Dr Agarwal's Health Care IPO opens today: GMP up 3%; Should you subscribe?" has 1016 words across 36 sentences, which will take approximately 5 - 9 minutes for the average person to read.
Which news outlet covered this story?
The story "Dr Agarwal's Health Care IPO opens today: GMP up 3%; Should you subscribe?" was covered 1 days ago by Business Standard, a news publisher based in India.
How trustworthy is 'Business Standard' news outlet?
Business Standard is a fully independent (privately-owned) news outlet established in 1975 that covers mostly business and finance news.
The outlet is headquartered in India and publishes an average of 326 news stories per day.
It's most recent story was published 2 hours ago.
What do people currently think of this news story?
The sentiment for this story is currently Neutral, indicating that people are not responding positively or negatively to this news.
How do I report this news for inaccuracy?
You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.
